Dr. Jaya Krishna Chintanaboina, MD

Dr. Chintanaboina practices at Fresno Endoscopy Center in Fresno, California.

Dr. Chintanaboina's NPI, 1144478454, was assigned on August 29, 2008. Dr. Chintanaboina graduated from Sri Venkatesvara Medical College NTR in 2004. Dr. Chintanaboina's California license number on file is C156640.

Dr. Chintanaboina's primary practice is Fresno Endoscopy Center, at 7405 North Fresno Street, Fresno, CA 93720. The practice phone is (209) 438-9400.

Dr. Chintanaboina's primary practice is Fresno Endoscopy Center in Fresno, California. Dr. Chintanaboina is also affiliated with Community Regional Medical Center. The medical group on file is Inspire Health Medical Group. Dmand AI also links Dr. Chintanaboina to 3 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chintanaboina practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Chintanaboina's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Chintanaboina is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Chintanaboina's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroduodenitis and gastrointestinal bleeding among the conditions Dr. Chintanaboina treats.

CMS data shows 908 Medicare services from Dr. Chintanaboina across 14 procedure codes in 2024, for 318 Medicare patients. Medicare paid $99,611 for them.

CMS counts 318 Medicare patients who saw Dr. Chintanaboina in 2024. The largest group is 65 to 74, with 155 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chintanaboina's median patient age at 70, with 56% women.

In 2024, Dr. Chintanaboina wrote 1,139 Medicare Part D claims for 619 patients. 86% of them were for generic drugs. CMS names the drug for 995 of them, across 12 drugs with 11 or more claims each, at $97,348 in total drug cost. In 2023, CMS named 471 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Chintanaboina for performance year 2024, reported as part of a group. Dr. Chintanaboina accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 375 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Chintanaboina, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Chintanaboina, published from 2021 to 2022. 2022 was the busiest year, with 2. Dr. Chintanaboina has published most often in Cureus. Dr. Chintanaboina's most frequent co-authors are Hunza Chaudhry, MD, Armaan Dhaliwal and Steve Hu.

CMS Open Payments shows 172 general payments to Dr. Chintanaboina from 21 drug and device companies from 2016 to 2025. Grants make up the largest share, 94% of the total. Pfizer Inc. paid the most, $80,000.

Dr. Chintanaboina graduated from Sri Venkatesvara Medical College NTR in 2004. Dr. Chintanaboina is a member of ACG, ACP and SHM.

Dr. Chintanaboina is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Kaiser Permanente. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.